AI-assisted Prediction of Lymph Node Metastasis of Breast Cancer: Current and Prospective Research

DING Yan, HAN Meng-xue, LIU Yue-ping

Abstract

One of the most important application of artificial intelligence (AI) in pathology is prediction, using morphological features, of patient prognosis and response to specific treatments. As one of the most common kinds of malignancies in the world and the crucial important cause of death due to malignant tumor among women, breast cancer has become the center of attention in clinical services. Axillary lymph node metastasis is an important prognostic factor in breast cancer. The accuracy of the assessment of axillary lymph node metastasis bears heavily on clinical diagnosis and treatment. At present, based on the principle of non-invasive procedures, many studies have been done to develop models that can be used to predict sentinel lymph node metastasis of breast cancer. However, different clinical and pathological parameters are used in these predictive models. How to analyze the clinical and pathological data of breast cancer patients in a more comprehensive way and how to establish a prediction model with better precision have become the future direction of development. In this paper, we describe the research progress of AI in pathology and the current status of its use in breast cancer research. We have conducted in-depth reflection and looked into the future of ways to predict effectively breast cancer lymph node metastasis and to establish more accurate and effective deep-learning algorithm based on AI assistance so as to continuously improve the diagnosis and treatment of breast cancer.

 

Keywords: Artificial intelligence, Deep learning, Breast cancer, Lymph node metastasis

 

Full Text:

PDF


References


ESTEVA A， KUPREL B， NOVOA R A， et al. Dermatologist-level classification of skin cancer with deep neural networks. Nature，2017， 542(7639): 115–118.

KONG X， GONG S， SU L， et al. Automatic detection of acromegaly from facial photographs using machine learning methods. EBio Med， 2018，27: 94–102.

WEINSTEIN R S， GRAHAM A R， RICHTER L C， et al. Overview of telepathology, virtual microscopy, and whole slide imaging: prospects for the future. Hum Pathol，2009，40(8): 1057–1069.

ANTHIMOPOULOS M， CHRISTODOULIDIS S， EBNER L， et al. Lung pattern classification for interstitial lung diseases using a deep convolutional neural network. IEEE Trans Med Imaging，2016，35(5): 1207–1216.

XU Y， HOSNY A， ZELEZNIK R， et al. Deep learning predicts lung cancer treatment response from serial medical imaging. Clin Cancer Res， 2019，25(11): 3266–3275.

BI W L， HOSNY A， SCHABATH M B， et al. Artificial intelligence in cancer imaging: clinical challenges and applications. CA Cancer J Clin， 2019，69(2): 127–157.

TIZHOOSH H R， PANTANOWITZ L. Artificial intelligence and digital pathology: challenges and opportunities. J Pathol Inform， 2018， 9: 38[2020-09-23]. https://www.jpathinformatics.org/text.asp?2018/9/1/ 38/245402. doi: 10.4103/jpi.jpi_53_18.

DE FAUW J， LEDSAM J R， ROMERA-PAREDES B， et al. Clinically applicable deep learning for diagnosis and referral in retinal disease. Nat Med，2018，24(9): 1342–1350.

HOUSSAMI N， LEE C I， BUIST D S M， et al. Artificial intelligence for breast cancer screening: opportunity or hype? Breast，2017，36: 31–33.

FERRONI P， ZANZOTTO F M， RIONDINO S， et al. Breast cancer prognosis using a machine learning approach. Cancers (Basel)，2019， 11(3): 328.

HAN S， KANG H K， JEONG J Y， et al. A deep learning framework for supporting the classification of breast lesions in ultrasound images. Phys Med Biol，2017，62(19): 7714–7728.

SUTTON E J， DASHEVSKY B Z， OH J H， et al. Breast cancer molecular subtype classifier that incorporates MRI features. J Magn Reson Imaging， 2016，44(1): 122–129.

SOMASHEKHAR S P， SEPULVEDA M， PUGLIELLI S， et al. Watson for oncology and breast cancer treatment recommendations: agreement with an expert multidisciplinary tumor board. Ann Oncol，2018，29(2): 418–423.

TRAN W T， JERZAK K， LU F I， et al. Personalized breast cancer treatments using artificial intelligence in radiomics and pathomics. J Med Imaging Radiat Sci，2019，50(4 Suppl 2): S32–S41.

CAMPANELLA G， HANNA M G， GENESLAW L， et al. Clinical-grade computational pathology using weakly supervised deep learning on whole slide images. Nat Med，2019，25(8): 1301–1309.

MAMOUNAS E P， KUEHN T， RUTGERS E J T， et al. Current approach of the axilla in patients with early-stage breast cancer. Lancet， 2017: S0140-6736(17)31451-4[2020-09-23]. https://doi.org/10.1016/S0140-6736(17)31451-4. doi: 10.1016/S0140-6736(17)31451-4.

AMIN M B， EDGE S B， GREENE F L， et al. AJCC Cancer staging manual. 8th ed. New York: Springer， 2017.

BEJNORDI B E， VETA M， VAN DIEST P J， et al. Diagnostic assessment of deep learning algorithms for detection of lymph node metastases in women with breast cancer. JAMA，2017，318(22): 2199–2210.

DE GOURNAY E， GUYOMARD A， COUTANT C， et al. Impact of sentinel node biopsy on long-term quality of life in breast cancer patients. Br J Cancer，2013，109(11): 2783–2791.

MAGUIRE A， BROGI E. Sentinel lymph nodes for breast carcinoma: an update on current practice. Histopathology，2016，68(1): 152–167.

DIHGE L， OHLSSON M， EDÉN P， et al. Artificial neural network models to predict nodal status in clinically node-negative breast cancer. BMC Cancer，2019，19(1): 610.

WILKE L G， MCCALL L M， POSTHER K E， et al. Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial. Ann Surg Oncol，2006， 13(4): 491–500.

BEVILACQUA J L， KATTAN M W， FEY J V， et al. Doctor, what are my chances of having a positive sentinel node? A validated nomogram for risk estimation. J Clin Oncol，2007，25(24): 3670–3679.

LIU C， ZHAO Z， GU X， et al. Establishment and verification of a baggedtrees-based model for prediction of sentinel lymph node metastasis for early breast cancer patients. Front Oncol， 2019， 9: 282[2020-09-23]. https://doi.org/10.3389/fonc.2019.00282.


Refbacks

  • There are currently no refbacks.